Samuel R. McKee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samuel R. McKee has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Asya Smirnov
Department of Molecular Microbiology, Washington University School of Medicine
2 shared publications Chanchal Sur Chowdhury
Department of Molecular Microbiology, Center for Women’s Infectious Disease Research, Washington University School of Medicine, St Louis, USA
2 shared publications- Christina Leigh Stallings
Department of Molecular Microbiology, Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO 63110, USA
2 shared publications Darren Kreamalmeyer
Department of Molecular Microbiology, Center for Women’s Infectious Disease Research, Washington University School of Medicine, St Louis, USA
2 shared publications- Maxim N. Artyomov
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
2 shared publications Aaron Pride
Department of Molecular Microbiology, Center for Women’s Infectious Disease Research, Washington University School of Medicine, St Louis, USA
1 shared publication
Latest Publications
- 15 May 2025
- Published by Springer Nature in Nature Microbiology
- Vol. 10 (6) , 1323-1339
ATG5 suppresses type I IFN-dependent neutrophil effector functions during Mycobacterium tuberculosis infection in mice
Inflammation is critical for controlling infections but can cause disease when unchecked. During Mycobacterium tuberculosis (Mtb) infection, neutrophil-dominated inflammation is associated with exacerbated disease. ATG5 expression by neutrophils mediates autophagy-independent control of infection but mechanistic understanding of how this regulates protective neutrophil function is lacking. Using genetic mouse models along with in vivo and in vitro infection systems, we report herein that ATG5 is required in neutrophils to suppress type I interferon-induced PAD4-mediated histone citrullination and neutrophil extracellular trap (NET) release. In addition, ATG5 suppresses type I interferon-induced CXCL2 secretion and neutrophil swarming during Mtb infection. Elevated type I IFN signalling and NET release contribute to the early susceptibility of Atg5fl/fl-LysM-Cre mice during infection. These findings identify ATG5 as a master regulator of how type I interferon influences neutrophil responses during infection, revealing a potential target for host-directed therapies.
- 15 May 2025
- Published by Springer Nature in Nature Microbiology
- Vol. 10 (6) , 1323-1339
ATG5 suppresses type I IFN-dependent neutrophil effector functions during Mycobacterium tuberculosis infection in mice
Inflammation is critical for controlling infections but can cause disease when unchecked. During Mycobacterium tuberculosis (Mtb) infection, neutrophil-dominated inflammation is associated with exacerbated disease. ATG5 expression by neutrophils mediates autophagy-independent control of infection but mechanistic understanding of how this regulates protective neutrophil function is lacking. Using genetic mouse models along with in vivo and in vitro infection systems, we report herein that ATG5 is required in neutrophils to suppress type I interferon-induced PAD4-mediated histone citrullination and neutrophil extracellular trap (NET) release. In addition, ATG5 suppresses type I interferon-induced CXCL2 secretion and neutrophil swarming during Mtb infection. Elevated type I IFN signalling and NET release contribute to the early susceptibility of Atg5fl/fl-LysM-Cre mice during infection. These findings identify ATG5 as a master regulator of how type I interferon influences neutrophil responses during infection, revealing a potential target for host-directed therapies.
- Top Cited Papers
- 27 February 2024
- Published by Springer Nature in Nature Microbiology
- Vol. 9 (3) , 684-697
Autophagy promotes efficient T cell responses to restrict high-dose Mycobacterium tuberculosis infection in mice
Although autophagy sequesters Mycobacterium tuberculosis (Mtb) in in vitro cultured macrophages, loss of autophagy in macrophages in vivo does not result in susceptibility to a standard low-dose Mtb infection until late during infection, leaving open questions regarding the protective role of autophagy during Mtb infection. Here we report that loss of autophagy in lung macrophages and dendritic cells results in acute susceptibility of mice to high-dose Mtb infection, a model mimicking active tuberculosis. Rather than observing a role for autophagy in controlling Mtb replication in macrophages, we find that autophagy suppresses macrophage responses to Mtb that otherwise result in accumulation of myeloid-derived suppressor cells and subsequent defects in T cell responses. Our finding that the pathogen-plus-susceptibility gene interaction is dependent on dose has important implications both for understanding how Mtb infections in humans lead to a spectrum of outcomes and for the potential use of autophagy modulators in clinical medicine.
- 27 February 2024
- Published by Springer Nature in Nature Microbiology
- Vol. 9 (3) , 684-697
Top Cited PapersAutophagy promotes efficient T cell responses to restrict high-dose Mycobacterium tuberculosis infection in mice
Although autophagy sequesters Mycobacterium tuberculosis (Mtb) in in vitro cultured macrophages, loss of autophagy in macrophages in vivo does not result in susceptibility to a standard low-dose Mtb infection until late during infection, leaving open questions regarding the protective role of autophagy during Mtb infection. Here we report that loss of autophagy in lung macrophages and dendritic cells results in acute susceptibility of mice to high-dose Mtb infection, a model mimicking active tuberculosis. Rather than observing a role for autophagy in controlling Mtb replication in macrophages, we find that autophagy suppresses macrophage responses to Mtb that otherwise result in accumulation of myeloid-derived suppressor cells and subsequent defects in T cell responses. Our finding that the pathogen-plus-susceptibility gene interaction is dependent on dose has important implications both for understanding how Mtb infections in humans lead to a spectrum of outcomes and for the potential use of autophagy modulators in clinical medicine.